2.9
2.90 (0.46%)
As of Mar 06, 2024
Glycomimetics Inc [GLYC]
Source:
Company Overview
Glycomimetics Inc is a late-stage clinical development biotechnology company focused on improving the lives of people living with cancer and inflammatory diseases by leveraging the inhibition of carbohydrate interactions that occur on the surface of cells.
Country | United States |
Headquarters | rockville, maryland |
Phone Number | 240-243-1201 |
Industry | manufacturing |
CEO | Harout Semerjian |
Website | www.glycomimetics.com |